CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced three additions to its senior management team: Teresa Compton, PhD joined Akebia as Senior Vice President and Chief Scientific Officer, Ramin Farzaneh-Far, MD as Vice President of Medical Research, and Ed Joyce as Vice President, Investor Relations and Corporate Communications.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
